Price Alert

PureTech Health (PRTC)

NASDAQ: PRTC · Real-Time Price · USD

19.17

1.16 (6.44%)

At close: Aug 18, 2025, 3:56 PM

19.15

-0.10%

After-hours: Aug 18, 2025, 04:10 PM EDT

6.44% (1D)

Bid	13.73
Market Cap	487.12M
Revenue (ttm)	4.32M
Net Income (ttm)	53.51M
EPS (ttm)	2.1
PE Ratio (ttm)	9.13
Forward PE	-3.18
Analyst	Buy

Ask	19.67
Volume	577
Avg. Volume (20D)	3,825
Open	18.54
Previous Close	18.01
Day's Range	18.51 - 19.84
52-Week Range	13.30 - 25.00
Beta	0.86

About PRTC

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PRTC

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PRTC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

8 months ago

+8.85%

PureTech Health shares are trading higher after th... Unlock content with Pro Subscription

News

1 day ago · businesswire.com

PureTech Health: Notice of Half-Yearly Results

BOSTON--(BUSINESS WIRE)--PureTech Health: Notice of Half-Yearly Results.

5 days ago · businesswire.com

PureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint

BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint.